Home › Funds › Douglass Winthrop Advisors, LLC › JNJ

Douglass Winthrop Advisors, LLC position in JNJ

JOHNSON & JOHNSON · Health Care

Douglass Winthrop Advisors, LLC reported holding 103,125 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$27.3M, representing 0.48% of its reported portfolio and ranking #35 among its reported holdings. Douglass Winthrop Advisors, LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)103.12K sh
Reported value held$27.30M
Portfolio Weight0.48%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Douglass Winthrop Advisors, LLC's JNJ position evolved

Douglass Winthrop Advisors, LLC first disclosed a stake in JNJ in Q3 2023 at 116,227 shares (US$18.1M). The position peaked in Q3 2026 at 103,125 shares, worth US$27.3M. Across 13 filings, Douglass Winthrop Advisors, LLC increased the stake 5 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 103,125 shares valued at US$27.3M — a reduction of -1,401 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 116.23K $18.10M New
Q4 2023 114.29K $17.91M Reduce
Q1 2024 112.44K $17.79M Reduce
Q2 2024 102.44K $14.97M Reduce
Q3 2024 107.05K $17.35M Add
Q4 2024 109.41K $15.82M Add
Q1 2025 98.42K $16.32M Reduce
Q2 2025 97.08K $14.83M Reduce
Q3 2025 107.44K $19.92M Add
Q4 2025 108.35K $22.42M Add
Q1 2026 103.83K $25.38M Reduce
Q2 2026 104.53K $26.55M Add
Q3 2026 103.12K $27.30M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Douglass Winthrop Advisors, LLC held JNJ?

Douglass Winthrop Advisors, LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Douglass Winthrop Advisors, LLC's current position in JNJ?

As of Q3 2026, Douglass Winthrop Advisors, LLC holds 103.12K shares of JNJ (JOHNSON & JOHNSON), valued at $27.30M, representing 0.48% of its reported portfolio and ranking #35.

Has Douglass Winthrop Advisors, LLC been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Douglass Winthrop Advisors, LLC reduced its position in JNJ. The position peaked in Q3 2026 at 103.12K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.